Health Care & Life Sciences » Biotechnology | ImmunoVaccine Inc.

ImmunoVaccine Inc. | Key People and Executives

Frederic Ors
CEO, Director & Chief Business Officer
Julia P. Gregory
Director
Andrew J. Sheldon
Chairman
Shermaine Tilley
Independent Director
Alfred A. Smithers
Independent Director
Albert Scardino
Independent Director
James Willis Hall
Independent Director
Wayne F. Pisano
Independent Director
Frederic Ors
CEO, Director & Chief Business Officer
Pierre Labbé
Chief Financial Officer
Gabriela Nicola Rosu
Chief Medical Officer
Joseph Sullivan
Senior Vice President-Business Development
Marianne Stanford
Vice President-Research
Julia P. Gregory
Director
Andrew J. Sheldon
Chairman
Shermaine Tilley
Independent Director
Alfred A. Smithers
Independent Director
Albert Scardino
Independent Director
James Willis Hall
Independent Director
Wayne F. Pisano
Independent Director

About ImmunoVaccine

View Profile
Address
130 Eileen Stubbs Avenue
Dartmouth Nova Scotia B3B 2C4
Canada
Employees -
Website http://www.imv-inc.com
Updated 07/08/2019
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.